Clinical Trial Update: Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function [Phase 4]

View source ↗

Summary

Phase 4 safety update examining whether artemether-lumefantrine and other malaria drugs affect auditory function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• Coartem (artemether-lumefantrine)
• artemether (artemether)
• lumefantrine (lumefantrine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Malaria, Falciparum | Phase 4 | Status: TERMINATED